(Q34063824)

30 July 2017

title

Validity of assessing inhibitor development in haemophilia PUPs using registry data: the EUHASS project (English)

1 reference

30 July 2017

0 references

K Fischer

1

0 references

author name string

D Lewandowski

series ordinal

2

1 reference

30 July 2017

H Marijke van den Berg

series ordinal

3

1 reference

30 July 2017

M P Janssen

series ordinal

4

1 reference

30 July 2017

publication date

2 November 2011

1 reference

30 July 2017

1 reference

30 July 2017

volume

18

1 reference

30 July 2017

issue

3

1 reference

30 July 2017

page(s)

e241-6

1 reference

The epidemiology of inhibitors in haemophilia A: a systematic review

30 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2516.2011.02687.X

Polymorphisms in the TNFA gene and the risk of inhibitor development in patients with hemophilia A.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2516.2011.02687.X

Polymorphisms in the CTLA-4 gene and inhibitor development in patients with severe hemophilia A.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2516.2011.02687.X

Inhibitor development in correlation to factor VIII genotypes

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2516.2011.02687.X

Environmental risk factors for inhibitor development in children with haemophilia A: a case-control study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2516.2011.02687.X

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2516.2011.02687.X

Treatment characteristics and the risk of inhibitor development: a multicenter cohort study among previously untreated patients with severe hemophilia A.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2516.2011.02687.X

A Bayesian approach to the assessment of inhibitor risk in studies of factor VIII concentrates

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2516.2011.02687.X

Assessment of incidence of inhibitors in patients with haemophilia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2516.2011.02687.X

EUHASS: The European Haemophilia Safety Surveillance system

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2516.2011.02687.X

Risk stratification for inhibitor development at first treatment for severe hemophilia A: a tool for clinical practice

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2516.2011.02687.X

Changing pattern of care of boys with haemophilia in western European centres

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2516.2011.02687.X

Inhibitors in congenital coagulation disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2516.2011.02687.X

10.1111/J.1365-2516.2011.02687.X

21 January 2018

Identifiers

DOI

1 reference

30 July 2017

1 reference